|
Status |
Public on Apr 30, 2015 |
Title |
microRNA alterations associated to early relapse in advanced stage ovarian cancer patients (validation set) |
Organism |
Homo sapiens |
Experiment type |
Non-coding RNA profiling by array
|
Summary |
A set of 45 surgical specimens has been profiled for miRNA expression to validate miRNA alterations associated to early relapse in advanced stage ovarian cancer patients.
|
|
|
Overall design |
Fresh frozen samples were collected from a series of consecutive patients with high-grade advanced stage ovarian cancer who underwent primary surgery at INT-Milan. After surgery all patients received postoperative platinum-based chemotherapy. All patients signed an Institutional Review Board approved consent for bio-banking, clinical data collection and molecular analysis.
Clinical codes:
Histotype: according to WHO classification guidelines
Stage: according to International Federation of Gynecological and Obstetrics (FIGO) guidelines
Grading: according to WHO classification guidelines
Debulking: NED: not evident disease; mRD: minimal residual disease; GRD: gross residual disease
Therapy code: P: Platinum without taxanes; PT: Platinum/paclitaxel
|
|
|
Contributor(s) |
De Cecco L |
Citation(s) |
22246208 |
|
Submission date |
Apr 13, 2015 |
Last update date |
Feb 18, 2019 |
Contact name |
Loris De Cecco |
E-mail(s) |
loris.dececco@istitutotumori.mi.it
|
Organization name |
IRCSS Istituto Nazionale Tumori
|
Street address |
via Venezian 1
|
City |
Milan |
ZIP/Postal code |
20133 |
Country |
Italy |
|
|
Platforms (1) |
GPL8179 |
Illumina Human v2 MicroRNA expression beadchip |
|
Samples (45)
|
|
This SubSeries is part of SuperSeries: |
GSE25204 |
microRNA alterations associated to clinical response in advanced stage ovarian cancer patients |
|
Relations |
BioProject |
PRJNA280993 |